Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN<sup>®</sup> System Comprehensive Approach

Drug–Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN<sup>®</sup> System Comprehensive Approach

Drug–drug interactions (DDIs) can affect both treatment efficacy and toxicity. We used Drug-PIN<sup>®</sup> (Personalized Interactions Network) software in colorectal cancer (CRC) patients to evaluate drug–drug–gene interactions (DDGIs), defined as the combination of DDIs and individual...

Full description

Bibliographic Details
Main Authors: Michela Roberto, Alessandro Rossi, Martina Panebianco, Leda Marina Pomes, Giulia Arrivi, Debora Ierinò, Maurizio Simmaco, Paolo Marchetti, Federica Mazzuca
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pharmaceuticals
Subjects:
advanced colorectal cancer
pharmacogenomic
drug–drug–gene interaction
Drug-PIN<sup>®</sup>
Online Access:https://www.mdpi.com/1424-8247/14/1/67

Internet

https://www.mdpi.com/1424-8247/14/1/67

Similar Items